GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Qlife Holding AB (OSTO:QLIFE) » Definitions » Profitability Rank

Qlife Holding AB (OSTO:QLIFE) Profitability Rank : 0 (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Qlife Holding AB Profitability Rank?

Qlife Holding AB has the Profitability Rank of 0.

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:

1. Operating Margin %
2. Piotroski F-Score
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank

Qlife Holding AB's Operating Margin % for the quarter that ended in Sep. 2023 was -26,646.67%. As of today, Qlife Holding AB's Piotroski F-Score is 2.


Competitive Comparison of Qlife Holding AB's Profitability Rank

For the Medical Devices subindustry, Qlife Holding AB's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qlife Holding AB's Profitability Rank Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Qlife Holding AB's Profitability Rank distribution charts can be found below:

* The bar in red indicates where Qlife Holding AB's Profitability Rank falls into.



Qlife Holding AB Profitability Rank Calculation

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Qlife Holding AB has the Profitability Rank of 0.

Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.

Profitability Rank is based on these factors:

1. Operating Margin %

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Qlife Holding AB's Operating Margin % for the quarter that ended in Sep. 2023 is calculated as:

Operating Margin %=Operating Income (Q: Sep. 2023 ) / Revenue (Q: Sep. 2023 )
=-11.991 / 0.045
=-26,646.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2. Piotroski F-Score

Warning Sign:

Piotroski F-Score of 2 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

Qlife Holding AB has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.

4. Consistency of the profitability

5. Predictability Rank


Qlife Holding AB Profitability Rank Related Terms

Thank you for viewing the detailed overview of Qlife Holding AB's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Qlife Holding AB (OSTO:QLIFE) Business Description

Traded in Other Exchanges
Address
Redaregatan 48, Helsingborg, SWE, SE-252 36
Qlife Holding AB is a medical device company that seeks to revolutionize the clinical biomarker testing of whole blood by taking it out of the lab and into the homes of the people who needs it. The Egoo Home System is an integrated platform consisting of a small home device and disposable capsules, each of which tests for a specific biomarker. It provides a digital infrastructure for sharing the data with the patient's doctor, clinic or hospital via smartphone and computer.

Qlife Holding AB (OSTO:QLIFE) Headlines

No Headlines